Fig. 1From: eNOS polymorphisms as predictors of efficacy of bevacizumab-based chemotherapy in metastatic colorectal cancer: data from a randomized clinical trial VEGF and eNOS polymorphisms (with rs reference numbers) analyzed in the study.Back to article page